0001144204-17-026071.txt : 20170510 0001144204-17-026071.hdr.sgml : 20170510 20170510163035 ACCESSION NUMBER: 0001144204-17-026071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170508 FILED AS OF DATE: 20170510 DATE AS OF CHANGE: 20170510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: China Biologic Products, Inc. CENTRAL INDEX KEY: 0001369868 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 752308816 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100125 BUSINESS PHONE: 86-10-6598-3111 MAIL ADDRESS: STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100125 FORMER COMPANY: FORMER CONFORMED NAME: GRC Holdings, Inc. DATE OF NAME CHANGE: 20060721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liu Zhijing CBPO CENTRAL INDEX KEY: 0001575517 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34566 FILM NUMBER: 17830745 MAIL ADDRESS: STREET 1: 19 CHAOYANG PARK ROAD STREET 2: 18/F, JIALONG INTERNATIONAL BUILDING CITY: BEIJING STATE: F4 ZIP: 100125 4 1 v466479_4.xml OWNERSHIP DOCUMENT X0306 4 2017-05-08 0 0001369868 China Biologic Products, Inc. CBPO 0001575517 Liu Zhijing CBPO 18TH FLOOR, JIALONG INTERNATIONAL BUILDING, 19 CHAOYANG PARK ROAD BEIJING F4 100125 CHINA 0 1 0 0 Corporate Vice President Common Stock 2017-05-08 4 M 0 6358 9.85 A 10969 D Common Stock 2017-05-08 4 S 0 6358 116.68 D 4611 D Common Stock 2017-05-09 4 M 0 1142 9.85 A 5753 D Common Stock 2017-05-09 4 S 0 1142 115.40 D 4611 D Stock Option (right to buy) 9.85 2017-05-08 4 M 0 6358 D 2016-09-01 2022-08-31 Common Stock 6358 1142 D Stock Option (right to buy) 9.85 2017-05-09 4 M 0 1142 D 2016-09-01 2022-08-31 Common Stock 1142 0 D Represents 6,358 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options. Represents 6,358 shares of common stock sold on the open market at a weighted average price of $116.68 per share on May 8, 2017. Represents 1,142 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options. Represents 1,142 shares of common stock sold on the open market at a weighted average price of $115.40 per share on May 9, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $116.62 to $116.95, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $115.20 to $115.65, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 6. Represents previously reported stock options to purchase 15,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were vested annually over a 4-year period in four equal portions, with the initial vesting date being September 1, 2013. /s/ Liu Zhijing 2017-05-10